Nocera (NCRA) Stock Price, News & Analysis

Company Overview

Nocera (NASDAQ: NCRA) is a clinical-stage biotechnology company focused on the development of novel RNA-based therapeutics for the treatment of rare and debilitating neurological disorders. Leveraging proprietary messenger RNA (mRNA) platforms and lipid nanoparticle delivery systems, Nocera is pioneering targeted therapeutic approaches aimed at addressing diseases with high unmet medical need. The company’s research and development pipeline encompasses several preclinical and early-stage clinical programs, including treatments for inherited neurodegenerative conditions and central nervous system injuries.

Founded in 2016 as a spin-out from a leading academic research institution, Nocera has grown its capabilities through strategic partnerships with major academic medical centers and contract research organizations. Headquartered in Boston, Massachusetts, the company maintains additional research facilities in Germany and Singapore to support global clinical trial operations and regulatory activities. Nocera’s cross-functional team includes experts in molecular biology, pharmacology, translational medicine and regulatory affairs, all working collaboratively to advance its therapeutic candidates toward proof-of-concept and registration stages.

Under the leadership of Chief Executive Officer Dr. Sarah Kim, who brings more than two decades of experience in pharmaceutical development and biotechnology, Nocera has solidified its commitment to scientific innovation and patient-centric drug development. Dr. Kim is supported by Chief Scientific Officer Dr. Mark Rodriguez, a recognized authority in RNA therapeutics, and a management team with deep expertise in manufacturing scale-up, clinical development and commercialization strategies. Together, they are guiding Nocera’s vision of transforming promising laboratory discoveries into safe and effective treatments for patients worldwide.

Key Stats

• Today's Range: $1.00 to $1.09
• 50-Day Range: $0.94 to $1.17
• 52-Week Range: $0.70 to $2.09
• Volume: 105,902 shs
• Average Volume: 81,010 shs
• Market Capitalization: $15.09 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Nocera Stock Analysis - MarketRank™

Nocera scored higher than 1% of companies evaluated by MarketBeat, and ranked 150th out of 152 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Nocera.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nocera is -6.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nocera is -6.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nocera has a P/B Ratio of 3.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.83% of the float of Nocera has been sold short.

Short Interest Ratio / Days to Cover

Nocera has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nocera has recently increased by 59.23%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nocera does not currently pay a dividend.

Dividend Growth

Nocera does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.83% of the float of Nocera has been sold short.

Short Interest Ratio / Days to Cover

Nocera has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nocera has recently increased by 59.23%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Nocera this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nocera insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 5.30% of the stock of Nocera is held by insiders.

Percentage Held by Institutions

Only 1.26% of the stock of Nocera is held by institutions.

NCRA Stock Analysis - Frequently Asked Questions

How have NCRA shares performed this year?

Nocera's stock was trading at $0.8463 at the beginning of 2025. Since then, NCRA stock has increased by 24.1% and is now trading at $1.05.

How were Nocera's earnings last quarter?

Nocera, Inc. (NASDAQ:NCRA) released its quarterly earnings results on Thursday, May, 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $4.53 million during the quarter. Nocera had a negative net margin of 12.70% and a negative trailing twelve-month return on equity of 47.60%.

When did Nocera IPO?

Nocera (NCRA) raised $9 million in an IPO on Thursday, August 11th 2022. The company issued 2,400,000 shares at $3.50-$4.00 per share. Spartan Capital and Revere Securities acted as the underwriters for the IPO.

How do I buy shares of Nocera?

Shares of NCRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nocera own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nocera investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/19/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: FOOD - MISC/DIVERSIFIED
• Sub-Industry: Agriculture
• Current Symbol: NASDAQ:NCRA
• CIK: 1756180
• Web: www.nocera.company
• Phone: 886910163358
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.16)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.35 million
• Net Margins: -12.70%
• Pretax Margin: -14.15%
• Return on Equity: -47.60%
• Return on Assets: -35.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.81
• Quick Ratio: 1.79

Sales & Book Value

• Annual Sales: $17.01 million
• Price / Sales: 0.89
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.30 per share
• Price / Book: 3.50

Miscellaneous

• Outstanding Shares: 14,370,000
• Free Float: 13,606,000
• Market Cap: $15.09 million
• Optionable: Not Optionable
• Beta: 1.21